Literature DB >> 24621957

Identification and quantification of amyloid beta-related peptides in human plasma using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Naoki Kaneko1, Rie Yamamoto, Taka-Aki Sato, Koichi Tanaka.   

Abstract

Proteolytic processing of the amyloid precursor protein (APP) by β-secretase and γ-secretase leads to the generation and deposition of amyloid β (Aβ) in Alzheimer's disease (AD). N-terminally or C-terminally truncated Aβ variants have been found in human cerebrospinal fluid and cultured cell media using immunoprecipitation and mass spectrometry. Unfortunately, the profile of plasma Aβ variants has not been revealed due to the difficulty of isolating Aβ from plasma. We present here for the first time studies of Aβ and related peptides in human plasma. Twenty-two Aβ-related peptides including novel peptides truncated before the β-secretase site were detected in human plasma and 20 of the peptides were identified by tandem mass spectrometry. Using an internal standard, we developed a quantitative assay for the Aβ-related peptides and demonstrated plasma dilution linearity and the precision required for their quantitation. The present method should enhance the understanding of APP processing and clearance in AD progression.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24621957      PMCID: PMC3997810          DOI: 10.2183/pjab.90.104

Source DB:  PubMed          Journal:  Proc Jpn Acad Ser B Phys Biol Sci        ISSN: 0386-2208            Impact factor:   3.493


  40 in total

Review 1.  Metabolism of amyloid-beta peptide and Alzheimer's disease.

Authors:  Nobuhisa Iwata; Makoto Higuchi; Takaomi C Saido
Journal:  Pharmacol Ther       Date:  2005-08-19       Impact factor: 12.310

Review 2.  Alzheimer's disease: the amyloid cascade hypothesis.

Authors:  J A Hardy; G A Higgins
Journal:  Science       Date:  1992-04-10       Impact factor: 47.728

Review 3.  Biomarkers of Alzheimer disease in plasma.

Authors:  Michael C Irizarry
Journal:  NeuroRx       Date:  2004-04

Review 4.  Biological markers of amyloid beta-related mechanisms in Alzheimer's disease.

Authors:  Harald Hampel; Yong Shen; Dominic M Walsh; Paul Aisen; Les M Shaw; Henrik Zetterberg; John Q Trojanowski; Kaj Blennow
Journal:  Exp Neurol       Date:  2009-10-06       Impact factor: 5.330

5.  Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression.

Authors:  Stephen D Ginsberg; Melissa J Alldred; Scott E Counts; Anne M Cataldo; Rachael L Neve; Ying Jiang; Joanne Wuu; Moses V Chao; Elliott J Mufson; Ralph A Nixon; Shaoli Che
Journal:  Biol Psychiatry       Date:  2010-07-23       Impact factor: 13.382

6.  Quantification of the A beta peptide in Alzheimer's plaques by laser dissection microscopy combined with mass spectrometry.

Authors:  Pascal Rüfenacht; Andreas Güntert; Bernd Bohrmann; Axel Ducret; Heinz Döbeli
Journal:  J Mass Spectrom       Date:  2005-02       Impact factor: 1.982

7.  β-amyloid dynamics in human plasma.

Authors:  Yafei Huang; Rachel Potter; Wendy Sigurdson; Tom Kasten; Rose Connors; John C Morris; Tammie Benzinger; Mark Mintun; Tim Ashwood; Mats Ferm; Samantha L Budd; Randall J Bateman
Journal:  Arch Neurol       Date:  2012-12

8.  Characterization of beta-amyloid peptide from human cerebrospinal fluid.

Authors:  C Vigo-Pelfrey; D Lee; P Keim; I Lieberburg; D B Schenk
Journal:  J Neurochem       Date:  1993-11       Impact factor: 5.372

9.  Quantitative analysis of amyloid-beta peptides in cerebrospinal fluid using immunoprecipitation and MALDI-Tof mass spectrometry.

Authors:  Valentina Gelfanova; Richard E Higgs; Robert A Dean; David M Holtzman; Martin R Farlow; Eric R Siemers; Amechand Boodhoo; Yue-Wei Qian; Xiaohua He; Zhaoyan Jin; Deborah L Fisher; Karen L Cox; John E Hale
Journal:  Brief Funct Genomic Proteomic       Date:  2007-06-20

Review 10.  Amyloid precursor protein trafficking, processing, and function.

Authors:  Gopal Thinakaran; Edward H Koo
Journal:  J Biol Chem       Date:  2008-07-23       Impact factor: 5.157

View more
  20 in total

1.  The aqueous phase of Alzheimer's disease brain contains assemblies built from ∼4 and ∼7 kDa Aβ species.

Authors:  Jessica M Mc Donald; Tiernan T O'Malley; Wen Liu; Alexandra J Mably; Gunnar Brinkmalm; Erik Portelius; William M Wittbold; Matthew P Frosch; Dominic M Walsh
Journal:  Alzheimers Dement       Date:  2015-04-04       Impact factor: 21.566

Review 2.  [New biomarkers for Alzheimer's disease in cerebrospinal fluid and blood].

Authors:  Jonathan Vogelgsang; Jens Wiltfang
Journal:  Nervenarzt       Date:  2019-09       Impact factor: 1.214

3.  High performance plasma amyloid-β biomarkers for Alzheimer's disease.

Authors:  Akinori Nakamura; Naoki Kaneko; Victor L Villemagne; Takashi Kato; James Doecke; Vincent Doré; Chris Fowler; Qiao-Xin Li; Ralph Martins; Christopher Rowe; Taisuke Tomita; Katsumi Matsuzaki; Kenji Ishii; Kazunari Ishii; Yutaka Arahata; Shinichi Iwamoto; Kengo Ito; Koichi Tanaka; Colin L Masters; Katsuhiko Yanagisawa
Journal:  Nature       Date:  2018-01-31       Impact factor: 49.962

4.  Aggregation and Fibril Structure of AβM01-42 and Aβ1-42.

Authors:  Robert Silvers; Michael T Colvin; Kendra K Frederick; Angela C Jacavone; Susan Lindquist; Sara Linse; Robert G Griffin
Journal:  Biochemistry       Date:  2017-08-30       Impact factor: 3.162

5.  Multiplex immunoassay measurement of amyloid-β42 to amyloid-β40 ratio in plasma discriminates between dementia due to Alzheimer's disease and dementia not due to Alzheimer's disease.

Authors:  Jonathan Vogelgsang; Hedieh Shahpasand-Kroner; Rebekka Vogelgsang; Frank Streit; Ruth Vukovich; Jens Wiltfang
Journal:  Exp Brain Res       Date:  2018-02-26       Impact factor: 1.972

6.  N-Terminal Extensions Retard Aβ42 Fibril Formation but Allow Cross-Seeding and Coaggregation with Aβ42.

Authors:  Olga Szczepankiewicz; Björn Linse; Georg Meisl; Eva Thulin; Birgitta Frohm; Carlo Sala Frigerio; Michael T Colvin; Angela C Jacavone; Robert G Griffin; Tuomas Knowles; Dominic M Walsh; Sara Linse
Journal:  J Am Chem Soc       Date:  2015-11-17       Impact factor: 15.419

7.  Novel plasma biomarker surrogating cerebral amyloid deposition.

Authors:  Naoki Kaneko; Akinori Nakamura; Yukihiko Washimi; Takashi Kato; Takashi Sakurai; Yutaka Arahata; Masahiko Bundo; Akinori Takeda; Shumpei Niida; Kengo Ito; Kenji Toba; Koichi Tanaka; Katsuhiko Yanagisawa
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2014       Impact factor: 3.493

Review 8.  Monomer-dependent secondary nucleation in amyloid formation.

Authors:  Sara Linse
Journal:  Biophys Rev       Date:  2017-08-15

9.  Assuring Consistent Performance of an Insulin-Like Growth Factor 1 MALDImmunoassay by Monitoring Measurement Quality Indicators.

Authors:  Frank Klont; Nick H T Ten Hacken; Péter Horvatovich; Stephan J L Bakker; Rainer Bischoff
Journal:  Anal Chem       Date:  2017-05-10       Impact factor: 6.986

10.  Identification of citrullinated peptides in the synovial fluid of patients with rheumatoid arthritis using LC-MALDI-TOF/TOF.

Authors:  Fei Wang; Fang-Fang Chen; Wen-Bo Gao; Hai-Yong Wang; Ning-Wei Zhao; Min Xu; De-Yu Gao; Wei Yu; Xiao-Ling Yan; Jian-Ning Zhao; Xiao-Jun Li
Journal:  Clin Rheumatol       Date:  2016-04-08       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.